PA
KYMR icon

Profund Advisors’s Kymera Therapeutics KYMR Stock Holding History

Profund Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Sell
18,455
-6,688
-27% -$575K 0.06% 184
2026
Q1 		$2.09M Buy
25,143
+2,903
+13% +$230K 0.08% 191
2025
Q4 		$1.73M Buy
22,240
+7,227
+48% +$488K 0.05% 244
2025
Q3 		$850K Buy
15,013
+6,182
+70% +$279K 0.03% 371
2025
Q2 		$385K Sell
8,831
-3,718
-30% -$128K 0.01% 558
2025
Q1 		$343K Buy
12,549
+1,052
+9% +$38.3K 0.01% 616
2024
Q4 		$463K Sell
11,497
-1,814
-14% -$81.9K 0.02% 562
2024
Q3 		$630K Sell
13,311
-3,700
-22% -$163K 0.02% 446
2024
Q2 		$508K Sell
17,011
-15,814
-48% -$548K 0.02% 489
2024
Q1 		$1.32M Buy
32,825
+12,938
+65% +$463K 0.05% 279
2023
Q4 		$506K Sell
19,887
-5,567
-22% -$99.6K 0.02% 515
2023
Q3 		$354K Sell
25,454
-13,375
-34% -$269K 0.02% 584
2023
Q2 		$893K Buy
38,829
+91
+0.2% +$2.61K 0.05% 342
2023
Q1 		$1.15M Buy
+38,738
New +$1.25M 0.07% 269

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Profund Advisors's KYMR Position: Q2 2026 in Review

Profund Advisors reduced its Kymera Therapeutics (KYMR) stake by 27% in Q2 2026, selling an estimated $575K and leaving 18,455 shares worth $2.12M. The position accounts for 0.06% of the portfolio, ranked #184.

Profund Advisors first reported a position in KYMR in Q1 2023 and has held it in 14 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Profund Advisors held 18,455 shares of Kymera Therapeutics worth $2.12M as of Q2 2026.
  • Profund Advisors sold 6,688 Kymera Therapeutics shares in Q2 2026, an estimated $575K.
  • Kymera Therapeutics made up 0.06% of Profund Advisors's portfolio in Q2 2026, its #184 holding.
  • Profund Advisors first reported a position in Kymera Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.